Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Oct;9(5):676-678.
doi: 10.21037/hbsn.2020.03.06.

Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?

José Ursic-Bedoya  1 , Boris Guiu  2
Affiliations
Editorial

Hepatocellular carcinoma chemoprevention in chronic hepatitis B patients: all-in on statins?

José Ursic-Bedoya et al. Hepatobiliary Surg Nutr. 2020 Oct.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: Both authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/hbsn.2020.03.06). The authors have no conflicts of interest to declare.

Comment on

References

    1. Seto WK, Lo YR, Pawlotsky JM, et al. Chronic hepatitis B virus infection. Lancet 2018;392:2313-24. 10.1016/S0140-6736(18)31865-8 - DOI - PubMed
    1. Fattovich G, Bortolotti F, Donato F. Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors. J Hepatol 2008;48:335-52. 10.1016/j.jhep.2007.11.011 - DOI - PubMed
    1. Wu CY, Lin JT, Ho HJ, et al. Association of nucleos(t)ide analogue therapy with reduced risk of hepatocellular carcinoma in patients with chronic hepatitis B: a nationwide cohort study. Gastroenterology 2014;147:143-51.e5. 10.1053/j.gastro.2014.03.048 - DOI - PubMed
    1. Choi J, Han S, Kim N, et al. Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population. Hepatology 2017;66:1454-63. 10.1002/hep.29321 - DOI - PubMed
    1. Fujiwara N, Friedman SL, Goossens N, et al. Risk factors and prevention of hepatocellular carcinoma in the era of precision medicine. J Hepatol 2018;68:526-49. 10.1016/j.jhep.2017.09.016 - DOI - PMC - PubMed